StockNews.com started coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a report issued on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock.
Calithera Biosciences Stock Performance
Shares of NASDAQ CALA opened at $0.02 on Thursday. The company has a 50-day moving average price of $0.01 and a 200-day moving average price of $0.02. Calithera Biosciences has a 1 year low of $0.00 and a 1 year high of $0.13.
Calithera Biosciences Company Profile
Recommended Stories
- Five stocks we like better than Calithera Biosciences
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Is Merck Stock Undervalued After Its Colossal Earnings Growth?
- Stock Market Sectors: What Are They and How Many Are There?
- Top 5 ETFs for Every Investor: From Semiconductors to Defense
- The 3 Best Blue-Chip Stocks to Buy Now
- Blade Air Mobility: This Under-the-Radar Stock Could Double Soon
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
